Interventional once-daily administration of ceftriaxone in leukemia and lymphoma patients with febrile neutropenia.
Karthaus
M
M
Abteilung Hämatologie und Onkologie, Medizinische Hochschule, Hannover. mkarthaus@gmx.de
Südhoff
T
T
Egerer
G
G
Fenchel
K
K
Kämpfe
D
D
Ritter
J
J
Franke
A
A
Heil
G
G
Peters
G
G
Jürgens
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control*; D002443:Ceftriaxone / Q000008:administration & dosage*; D002511:Cephalosporins / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000150:complications* / Q000188:drug therapy; D008223:Lymphoma / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D002511:Cephalosporins; D002443:Ceftriaxone